Drug Information and Safety Flashcards

What is a black box warning and what is its significance?

Answer: The FDA's/SFDA's strongest safety warning required on drug labeling, indicating serious or life-threatening risks

Black box (boxed) warnings are the most serious safety warnings, highlighting potentially fatal or disabling adverse effects. Examples: fluoroquinolones (tendon rupture), antidepressants (suicidality in youth), warfarin (bleeding). Pharmacists must counsel patients about these risks.

What is medication therapy management (MTM) and what are its components?

Answer: A comprehensive service including medication review, action plan development, intervention documentation, and follow-up evaluation to optimize therapy

MTM includes five core elements: medication therapy review (comprehensive assessment), personal medication record, medication action plan, intervention and referral, and documentation/follow-up. Saudi clinical pharmacists provide MTM to complex patients to optimize outcomes and reduce medication-related problems.

What is the SFDA's Classification system for newly registered drugs?

Answer: SFDA classifies drugs based on therapeutic need, innovation, and evidence, prioritizing review of drugs addressing unmet medical needs

SFDA uses a tiered registration review system that prioritizes: drugs addressing unmet medical needs in Saudi Arabia, orphan drugs, biosimilars, and innovative therapies. Standard review tracks exist for generic drugs with established safety profiles.

What is the pharmacist's role in poison information and toxicology?

Answer: Providing initial poisoning management guidance, identifying antidotes, calculating decontamination needs, and supporting the poison control center

Pharmacists in toxicology: provide initial poisoning assessment and management guidance, identify appropriate antidotes (N-acetylcysteine for acetaminophen, naloxone for opioids), advise on decontamination (activated charcoal timing), support the Saudi Poison Control Center, and manage drug overdose cases.

How should pharmacists manage patient medication adherence challenges?

Answer: Identify barriers (complexity, cost, side effects, beliefs), simplify regimens, use adherence aids, provide education, and follow up regularly

Adherence management: identify barriers using motivational interviewing, simplify regimens (reduce pill burden, use combination products), recommend pill organizers/reminder apps, address cost concerns (generic alternatives), manage side effects, provide culturally appropriate education, and schedule follow-up.

What is the role of clinical decision support systems (CDSS) in pharmacy practice?

Answer: Computerized systems that alert pharmacists to drug interactions, allergies, dosing errors, and duplicate therapy during order verification

CDSS in pharmacy: provides real-time alerts for drug-drug and drug-allergy interactions, flags dosing errors (renal adjustment needed), identifies duplicate therapy, checks formulary compliance, and supports clinical decision-making. The pharmacist evaluates and acts on alerts — the system supports, not replaces, clinical judgment.